PMC:7228307 / 869-1085 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"20","span":{"begin":71,"end":75},"obj":"Gene"}],"attributes":[{"id":"A20","pred":"tao:has_database_id","subj":"20","obj":"Gene:2213"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"The use of mAb therapeutics has also revealed a “scaffolding” role for FcγR which, in different contexts, may either underpin the therapeutic mAb action such as immune agonism or trigger catastrophic adverse effects."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T11","span":{"begin":28,"end":31},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T12","span":{"begin":46,"end":47},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T13","span":{"begin":71,"end":73},"obj":"http://purl.obolibrary.org/obo/CLO_0052676"}],"text":"The use of mAb therapeutics has also revealed a “scaffolding” role for FcγR which, in different contexts, may either underpin the therapeutic mAb action such as immune agonism or trigger catastrophic adverse effects."}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"20","span":{"begin":71,"end":75},"obj":"Gene"}],"attributes":[{"id":"A20","pred":"pubann:denotes","subj":"20","obj":"Gene:2213"}],"text":"The use of mAb therapeutics has also revealed a “scaffolding” role for FcγR which, in different contexts, may either underpin the therapeutic mAb action such as immune agonism or trigger catastrophic adverse effects."}

{"project":"LitCovid-sample-sentences","denotations":[{"id":"T9","span":{"begin":0,"end":216},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The use of mAb therapeutics has also revealed a “scaffolding” role for FcγR which, in different contexts, may either underpin the therapeutic mAb action such as immune agonism or trigger catastrophic adverse effects."}

{"project":"LitCovid-sentences","denotations":[{"id":"T9","span":{"begin":0,"end":216},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The use of mAb therapeutics has also revealed a “scaffolding” role for FcγR which, in different contexts, may either underpin the therapeutic mAb action such as immune agonism or trigger catastrophic adverse effects."}